Next Article in Journal
Perception of Health, Mistrust, Anxiety, and Indecision in a Group of Italians Vaccinated against COVID-19
Next Article in Special Issue
Seroprevalence of SARS-CoV-2 Antibodies in Symptomatic Individuals Is Higher than in Persons Who Are at Increased Risk Exposure: The Results of the Single-Center, Prospective, Cross-Sectional Study
Previous Article in Journal
Association between Antiviral Prophylaxis and Cytomegalovirus and Epstein–Barr Virus DNAemia in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplant
Previous Article in Special Issue
Titers, Prevalence, and Duration of SARS-CoV-2 Antibodies in a Local COVID-19 Outbreak and Following Vaccination
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Characterization of Immune Responses to SARS-CoV-2 and Other Human Pathogenic Coronaviruses Using a Multiplex Bead-Based Immunoassay

1
Institute of Virology, Department of Hygiene, Microbiology and Public Health, Medical University of Innsbruck, 6020 Innsbruck, Austria
2
Thermo Fisher Scientific, Bender MedSystems GmbH, Campus Vienna Biocenter 2, 1030 Vienna, Austria
*
Author to whom correspondence should be addressed.
Vaccines 2021, 9(6), 611; https://doi.org/10.3390/vaccines9060611
Submission received: 7 May 2021 / Revised: 31 May 2021 / Accepted: 2 June 2021 / Published: 7 June 2021
(This article belongs to the Special Issue SARS-CoV-2 Serological Studies around the Globe)

Abstract

Serological assays that simultaneously detect antibodies to multiple targets of SARS-CoV-2 and to other structurally related coronaviruses provide a holistic picture of antibody response patterns. Well-validated multiplex immunoassays are scarce. Here, we evaluated the performance of an 11-plex serological assay capable of detecting antibodies directed to four antigenic targets of SARS-CoV-2 and to S1 proteins of other human pathogenic coronaviruses. We used 620 well-characterized sera (n = 458 seropositive and n = 110 seronegative for SARS-CoV-2 in the pre-SARS-CoV-2 era and n = 52 seronegative for SARS-CoV-2 in the era of SARS-CoV-2) as positive and negative standards. We calculated the sensitivity, specificity, as well as positive and negative predictive values, including a 95% confidence interval. The difference in mean fluorescence intensity (95% CI) was used to assess a potential cross-reaction between antibodies to SARS-CoV-2 and the other coronaviruses. The sensitivity (95% CI) of detecting anti-SARS-CoV-2 antibodies to four antigenic targets ranged from 83.4% (76.7–86.7) to 93.7% (91.0–95.7) and the specificity from 98.2% (93.6–99.8) to 100% (96.7–100). We observed no obvious cross-reaction between anti-SARS-CoV-2 antibodies and antibodies to the other coronaviruses except for SARS-CoV-1. The high sensitivity and specificity warrant a reliable utilization of the assay in population-based seroprevalence surveys or vaccine efficacy studies.
Keywords: human coronaviruses; multiplex immunoassay; cross-reaction; bead-based immunoassay human coronaviruses; multiplex immunoassay; cross-reaction; bead-based immunoassay

Share and Cite

MDPI and ACS Style

Borena, W.; Kimpel, J.; Gierer, M.; Rössler, A.; Riepler, L.; Oehler, S.; von Laer, D.; Miholits, M. Characterization of Immune Responses to SARS-CoV-2 and Other Human Pathogenic Coronaviruses Using a Multiplex Bead-Based Immunoassay. Vaccines 2021, 9, 611. https://doi.org/10.3390/vaccines9060611

AMA Style

Borena W, Kimpel J, Gierer M, Rössler A, Riepler L, Oehler S, von Laer D, Miholits M. Characterization of Immune Responses to SARS-CoV-2 and Other Human Pathogenic Coronaviruses Using a Multiplex Bead-Based Immunoassay. Vaccines. 2021; 9(6):611. https://doi.org/10.3390/vaccines9060611

Chicago/Turabian Style

Borena, Wegene, Janine Kimpel, Melanie Gierer, Annika Rössler, Lydia Riepler, Susanne Oehler, Dorothee von Laer, and Markus Miholits. 2021. "Characterization of Immune Responses to SARS-CoV-2 and Other Human Pathogenic Coronaviruses Using a Multiplex Bead-Based Immunoassay" Vaccines 9, no. 6: 611. https://doi.org/10.3390/vaccines9060611

APA Style

Borena, W., Kimpel, J., Gierer, M., Rössler, A., Riepler, L., Oehler, S., von Laer, D., & Miholits, M. (2021). Characterization of Immune Responses to SARS-CoV-2 and Other Human Pathogenic Coronaviruses Using a Multiplex Bead-Based Immunoassay. Vaccines, 9(6), 611. https://doi.org/10.3390/vaccines9060611

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop